320 related articles for article (PubMed ID: 15529609)
1. The effect of two antidiarrhoeal drugs on the psychosocial adjustment to illness in chronic functional diarrhoea.
Dumitrascu DL; Stanculete M; Mitrea I; Dumitrascu DM; Farcas A
Rom J Intern Med; 2004; 42(1):191-7. PubMed ID: 15529609
[TBL] [Abstract][Full Text] [Related]
2. The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome.
Dumitraşcu DL; Stănculete M
Rom J Intern Med; 2006; 44(3):273-80. PubMed ID: 18386606
[TBL] [Abstract][Full Text] [Related]
3. Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea.
Kuge T; Shibata T; Willett MS
Clin Ther; 2004 Oct; 26(10):1644-51. PubMed ID: 15598481
[TBL] [Abstract][Full Text] [Related]
4. Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea.
Dupont C; Foo JL; Garnier P; Moore N; Mathiex-Fortunet H; Salazar-Lindo E;
Clin Gastroenterol Hepatol; 2009 Apr; 7(4):456-62. PubMed ID: 19268266
[TBL] [Abstract][Full Text] [Related]
5. The role of loperamide in gastrointestinal disorders.
Hanauer SB
Rev Gastroenterol Disord; 2008; 8(1):15-20. PubMed ID: 18477966
[TBL] [Abstract][Full Text] [Related]
6. Loperamide: a new antidiarrheal agent in the treatment of chronic diarrhea.
Galambos JT; Hersh T; Schroder S; Wenger J
Gastroenterology; 1976 Jun; 70(6):1026-9. PubMed ID: 773735
[TBL] [Abstract][Full Text] [Related]
7. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
Mystakidou K; Katsouda E; Tsilika E; Smyrniotis V; Vassiliou I; Tsiatas M; Vlahos L
Anticancer Res; 2006; 26(3B):2325-8. PubMed ID: 16821610
[TBL] [Abstract][Full Text] [Related]
8. Predictors of psychosocial adjustment in people with physical disease.
Kocaman N; Kutlu Y; Ozkan M; Ozkan S
J Clin Nurs; 2007 Mar; 16(3A):6-16. PubMed ID: 17518864
[TBL] [Abstract][Full Text] [Related]
9. Loperamide in chronic diarrhea and after ileostomy: a placebo-controlled double-blind cross-over study.
Tytgat GN; Huibregtse K; Meuwissen SG
Arch Chir Neerl; 1976; 28(1):13-20. PubMed ID: 779663
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of diosmectite in acute diarrhea in children].
Milocco C; Bolis A; Rizzo V; Suprani T; Cerasoli G; Marani M; Pocecco M
Pediatr Med Chir; 1999; 21(3):129-33. PubMed ID: 10687162
[TBL] [Abstract][Full Text] [Related]
11. Toddler diarrhoea: observations on the effects of aspirin and loperamide.
Hamdi I; Dodge JA
J Pediatr Gastroenterol Nutr; 1985 Jun; 4(3):362-5. PubMed ID: 3926980
[TBL] [Abstract][Full Text] [Related]
12. Refining a health-related quality of life assessment strategy for solid organ transplant patients.
Feurer ID; Moore DE; Speroff T; Liu H; Payne J; Harrison C; Pinson CW
Clin Transplant; 2004; 18 Suppl 12():39-45. PubMed ID: 15217406
[TBL] [Abstract][Full Text] [Related]
13. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
[TBL] [Abstract][Full Text] [Related]
14. First-line treatment in acute non-dysenteric diarrhoea: clinical comparison of loperamide oxide, loperamide and placebo. UK Janssen Research Group of General Practitioners.
Hughes IW
Br J Clin Pract; 1995; 49(4):181-5. PubMed ID: 7547157
[TBL] [Abstract][Full Text] [Related]
15. The influence of life stage on psychosocial adjustment in colorectal cancer patients.
Nishigaki M; Kazuma K; Oya M; Ueno M; Arai M; Yamaguchi T; Muto T
J Psychosoc Oncol; 2007; 25(4):71-87. PubMed ID: 18032266
[TBL] [Abstract][Full Text] [Related]
16. Treatment of travellers' diarrhoea: zaldaride compared with loperamide and placebo.
Silberschmidt G; Schick MT; Steffen R; Kilpatrick ME; Murphy JR; Oyofo BA; el-Etr S; Gyurech D; Mourad AS; Mathewson JT
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):871-5. PubMed ID: 8574720
[TBL] [Abstract][Full Text] [Related]
17. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
Topkan E; Karaoglu A
Oncology; 2006; 71(5-6):354-60. PubMed ID: 17873499
[TBL] [Abstract][Full Text] [Related]
18. Loperamide, a new antidiarrheal agent in the treatment of chronic diarrhea.
Galambos JT
Schweiz Med Wochenschr; 1978 Jul; 108(28):1080-1. PubMed ID: 97779
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
Chang FY; Lu CL; Chen CY; Luo JC
J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
[TBL] [Abstract][Full Text] [Related]
20. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
